<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Stock Blog Hub &#187; Pacific Booker Minerals Inc.</title>
	<atom:link href="http://www.stockbloghub.com/tag/pacific-booker-minerals-inc/feed" rel="self" type="application/rss+xml" />
	<link>http://www.stockbloghub.com</link>
	<description>Start Your Investing Research Here!</description>
	<lastBuildDate>Wed, 23 May 2012 20:22:08 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.3.2</generator>
		<item>
		<title>(CHSI) SXC Health Solutions to Buy Catalyst Health</title>
		<link>http://www.stockbloghub.com/2012/04/21/chsi-sxc-health-solutions-to-buy-catalyst-health/99404</link>
		<comments>http://www.stockbloghub.com/2012/04/21/chsi-sxc-health-solutions-to-buy-catalyst-health/99404#comments</comments>
		<pubDate>Sat, 21 Apr 2012 20:20:21 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Financial]]></category>
		<category><![CDATA[Insurance Brokers]]></category>
		<category><![CDATA[Barclays plc]]></category>
		<category><![CDATA[BCS]]></category>
		<category><![CDATA[C]]></category>
		<category><![CDATA[Catalyst Health Solutions Inc]]></category>
		<category><![CDATA[CHSI]]></category>
		<category><![CDATA[Citigroup Inc.]]></category>
		<category><![CDATA[CVS]]></category>
		<category><![CDATA[CVS Caremark Corporation]]></category>
		<category><![CDATA[ESRX]]></category>
		<category><![CDATA[Express Scripts Inc.]]></category>
		<category><![CDATA[Goldman Sachs Group]]></category>
		<category><![CDATA[GS]]></category>
		<category><![CDATA[JPM]]></category>
		<category><![CDATA[JPMorgan Chase & Company]]></category>
		<category><![CDATA[Pacific Booker Minerals Inc.]]></category>
		<category><![CDATA[PBM]]></category>
		<category><![CDATA[SXC Health Solutions Corporation]]></category>
		<category><![CDATA[SXCI]]></category>
		<category><![CDATA[UNH]]></category>
		<category><![CDATA[Unitedhealth Group Inc.]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=99404</guid>
		<description><![CDATA[On Wednesday, Catalyst Health Solutions Inc. (CHSI) announced that it has entered into a $4.4 billion takeover agreement with rival pharmacy benefits management (PBM) company, SXC Health Solutions Corp. (SXCI). As per the agreement, SXC Health will acquire Catalyst Health for $28 per share in cash and 0.6606 shares of SXC Health in exchange of every share of Catalyst Health. Considering the closing share price of the two companies on April 17, 2012, the agreement terms translate into a purchase price of $81.02 per share of Catalyst Health, representing a 28% premium on Catalyst’s closing price of $63.54 on April 17. Following the acquisition, the shareholders of SXC Health and Catalyst Health will own 65% and 35% of the combined company, respectively. The takeover is expected to be completed by ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2012/04/21/chsi-sxc-health-solutions-to-buy-catalyst-health/99404/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(CVS) Management Churn at CVS Caremark</title>
		<link>http://www.stockbloghub.com/2012/04/04/cvs-management-churn-at-cvs-caremark-analyst-blog/97427</link>
		<comments>http://www.stockbloghub.com/2012/04/04/cvs-management-churn-at-cvs-caremark-analyst-blog/97427#comments</comments>
		<pubDate>Wed, 04 Apr 2012 16:54:39 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Drug Stores]]></category>
		<category><![CDATA[Services]]></category>
		<category><![CDATA[AAI]]></category>
		<category><![CDATA[AirTran Holdings Inc]]></category>
		<category><![CDATA[CVS]]></category>
		<category><![CDATA[CVS Caremark Corporation]]></category>
		<category><![CDATA[ESRX]]></category>
		<category><![CDATA[Express Scripts Inc.]]></category>
		<category><![CDATA[First Trust Large Cap Gr Opp AlphaDEX]]></category>
		<category><![CDATA[FTC]]></category>
		<category><![CDATA[MedcoHealth Solutions Inc.]]></category>
		<category><![CDATA[MHS]]></category>
		<category><![CDATA[Pacific Booker Minerals Inc.]]></category>
		<category><![CDATA[PBM]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=97427</guid>
		<description><![CDATA[CVS Caremark Corporation (CVS) recently announced a change in top management. According to the company’s design, effective September 1, 2012, the present EVP and Chief Operating Officer of the Pharmacy Benefit Management (PBM) business, Jon Roberts will replace Per Lofberg, the President of the PBM business. However, Robert will continue to report to Lofberg who extended his employment agreement with the company till December 2013. September onwards, Lofberg will serve as the chairman of the PBM and look after the business strategies of PBM, new business development, client relationship management and retention and will directly report to Larry Merlo, the President and CEO of CVS Caremark. Rhode Island-based CVS Caremark is a combination of a PBM as well as retail drug chain. In terms of contractual arrangements with large plan ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2012/04/04/cvs-management-churn-at-cvs-caremark-analyst-blog/97427/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(MHS) Medco Healh Analyst Reiterates Shares at Neutral</title>
		<link>http://www.stockbloghub.com/2012/03/22/mhs-medco-healh-analyst-reiterates-shares-at-neutral/96119</link>
		<comments>http://www.stockbloghub.com/2012/03/22/mhs-medco-healh-analyst-reiterates-shares-at-neutral/96119#comments</comments>
		<pubDate>Thu, 22 Mar 2012 16:04:15 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Drug Stores]]></category>
		<category><![CDATA[Services]]></category>
		<category><![CDATA[AAI]]></category>
		<category><![CDATA[AirTran Holdings Inc]]></category>
		<category><![CDATA[CVS]]></category>
		<category><![CDATA[CVS Caremark Corporation]]></category>
		<category><![CDATA[ESRX]]></category>
		<category><![CDATA[Express Scripts Inc.]]></category>
		<category><![CDATA[FTC]]></category>
		<category><![CDATA[MedcoHealth Solutions Inc.]]></category>
		<category><![CDATA[MHS]]></category>
		<category><![CDATA[Pacific Booker Minerals Inc.]]></category>
		<category><![CDATA[PBM]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=96119</guid>
		<description><![CDATA[Recently, we reiterated our Neutral recommendation on Medco Health (MHS) with a target price of $74.00. During the fourth quarter of fiscal 2011, Medco reported adjusted EPS of $1.25, beating the Zacks Consensus Estimate of $1.17 and 26.3% higher than the year-ago level. Increased sales combined with 8.3% reduction in number of shares outstanding contributed to the bottom-line improvement during the quarter. Additionally, the introduction of generic Lipitor contributed $0.03 to the fourth quarter EPS. For the full year, adjusted EPS came in at $4.17, surpassing the Zacks Consensus Estimate of $4.10 and was up 17.5% year over year. In fiscal 2011, Medco’s top ten clients (based on revenues) contributed approximately 46% to net revenues. Besides, the largest client, UnitedHealth accounted for 17% of net revenues. However, in July 2011, ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2012/03/22/mhs-medco-healh-analyst-reiterates-shares-at-neutral/96119/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(WAG) Walgreen Inks Deal with AARP</title>
		<link>http://www.stockbloghub.com/2012/03/07/wag-walgreen-inks-deal-with-aarp/94117</link>
		<comments>http://www.stockbloghub.com/2012/03/07/wag-walgreen-inks-deal-with-aarp/94117#comments</comments>
		<pubDate>Wed, 07 Mar 2012 17:41:56 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Drug Stores]]></category>
		<category><![CDATA[Services]]></category>
		<category><![CDATA[ESRX]]></category>
		<category><![CDATA[Express Scripts Inc.]]></category>
		<category><![CDATA[Pacific Booker Minerals Inc.]]></category>
		<category><![CDATA[PBM]]></category>
		<category><![CDATA[WAG]]></category>
		<category><![CDATA[Walgreen Company]]></category>
		<category><![CDATA[WellPoint Inc.]]></category>
		<category><![CDATA[WLP]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=94117</guid>
		<description><![CDATA[Leading drugstore chain Walgreen (WAG) recently entered into a three-year contract with a nonprofit organization AARP, to deliver retail drugstore program benefits to its members belonging to the 50-plus age group. Although both the organizations did not disclose the financial terms of the deal, but together announced that this new deal is aimed at further enhancing their long standing relationship that was initiated in 2006. This new AARP program includes AARP membership card offers, AARP online discounts and Pharmacy benefits. Concurrently, both the companies together will also develop a new event called Walgreens Way to Well Health Tour in medically underserved areas plagued with chronic diseases. Under this event, they aim to provide medical coverage to approximately 100,000 people annually. This strategic move by Walgreen should help make up for ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2012/03/07/wag-walgreen-inks-deal-with-aarp/94117/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(CVS) CVS Caremark Corporation Ordered by FTC to Settle Claims</title>
		<link>http://www.stockbloghub.com/2012/01/13/cvs-cvs-caremark-corporation-ordered-by-ftc-to-settle-claims/90162</link>
		<comments>http://www.stockbloghub.com/2012/01/13/cvs-cvs-caremark-corporation-ordered-by-ftc-to-settle-claims/90162#comments</comments>
		<pubDate>Fri, 13 Jan 2012 21:05:38 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Drug Stores]]></category>
		<category><![CDATA[Services]]></category>
		<category><![CDATA[CVS]]></category>
		<category><![CDATA[CVS Caremark Corporation]]></category>
		<category><![CDATA[ESRX]]></category>
		<category><![CDATA[Express Scripts Inc.]]></category>
		<category><![CDATA[First Trust Large Cap Gr Opp AlphaDEX]]></category>
		<category><![CDATA[FTC]]></category>
		<category><![CDATA[MedcoHealth Solutions Inc.]]></category>
		<category><![CDATA[MHS]]></category>
		<category><![CDATA[Pacific Booker Minerals Inc.]]></category>
		<category><![CDATA[PBM]]></category>
		<category><![CDATA[WAG]]></category>
		<category><![CDATA[Walgreen Company]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=90162</guid>
		<description><![CDATA[Recently CVS Caremark Corporation (CVS) was asked by the Federal Trade Commission (FTC) to pay $5 million to settle all claims related to the company’s misrepresentation of prices of certain Medicare Part D prescription drugs at CVS Caremark and Walgreen (WAG)  pharmacies. The FTC alleged that from 2007 through November 2008, CVS Caremark’s subsidiary RxAmerica posted wrong prices on its website for prescription drugs including medications to treat epilepsy and symptoms of breast cancer. It also provided incorrect prices for posting to Plan Finder and third-party websites. The cases were extremely misleading for several seniors and disabled customers as the posted prices were 10 times below the actual prices of the drugs. This fake interpretation encouraged patients to opt for RxAmerica’s plans, which later pushed them into the &#8220;doughnut hole” ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2012/01/13/cvs-cvs-caremark-corporation-ordered-by-ftc-to-settle-claims/90162/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(WAG) Walgreens 2012 First Quarter Earnings Scorecard</title>
		<link>http://www.stockbloghub.com/2012/01/09/wag-walgreens-2012-first-quarter-earnings-scorecard/89426</link>
		<comments>http://www.stockbloghub.com/2012/01/09/wag-walgreens-2012-first-quarter-earnings-scorecard/89426#comments</comments>
		<pubDate>Mon, 09 Jan 2012 16:55:37 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Drug Stores]]></category>
		<category><![CDATA[Services]]></category>
		<category><![CDATA[CVS]]></category>
		<category><![CDATA[CVS Caremark Corporation]]></category>
		<category><![CDATA[ESRX]]></category>
		<category><![CDATA[Express Scripts Inc.]]></category>
		<category><![CDATA[MedcoHealth Solutions Inc.]]></category>
		<category><![CDATA[MHS]]></category>
		<category><![CDATA[Pacific Booker Minerals Inc.]]></category>
		<category><![CDATA[PBM]]></category>
		<category><![CDATA[RAD]]></category>
		<category><![CDATA[Rite Aid Corporation]]></category>
		<category><![CDATA[WAG]]></category>
		<category><![CDATA[Walgreen Company]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=89426</guid>
		<description><![CDATA[Subsequent to the announcement of Walgreen’s (WAG) first quarter 2012 (ended November 30) results on December 21, 2011, majority of the analysts have reduced their estimates for the forthcoming period. Previous Quarter Highlights Walgreen reported first quarter 2012 EPS of 63 cents, a penny higher than the year-ago quarter earnings but missed the Zacks Consensus Estimate of 67 cents. The result includes a negative impact of 1 cent per share related to the delay in the cough/cold and flu season, 1 cent in comparable pharmacy sales related to the non-renewal of the Express Script (ESRX) contract and 1 cent in related expenses. Revenues rose 4.7% year over year to $18.2 billion and were in line with the Zacks Consensus Estimate. Comparable store sales (those open for more than a year) ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2012/01/09/wag-walgreens-2012-first-quarter-earnings-scorecard/89426/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(CVS) CVS Caremark Corporation to Attend Healthcare Conference</title>
		<link>http://www.stockbloghub.com/2011/12/30/cvs-cvs-caremark-corporation-to-attend-healthcare-conference/89481</link>
		<comments>http://www.stockbloghub.com/2011/12/30/cvs-cvs-caremark-corporation-to-attend-healthcare-conference/89481#comments</comments>
		<pubDate>Fri, 30 Dec 2011 18:17:10 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Drug Stores]]></category>
		<category><![CDATA[Services]]></category>
		<category><![CDATA[AET]]></category>
		<category><![CDATA[Aetna Inc.]]></category>
		<category><![CDATA[CVS]]></category>
		<category><![CDATA[CVS Caremark Corporation]]></category>
		<category><![CDATA[ESRX]]></category>
		<category><![CDATA[Express Scripts Inc.]]></category>
		<category><![CDATA[MedcoHealth Solutions Inc.]]></category>
		<category><![CDATA[MHS]]></category>
		<category><![CDATA[Pacific Booker Minerals Inc.]]></category>
		<category><![CDATA[PBM]]></category>
		<category><![CDATA[UAM]]></category>
		<category><![CDATA[Universal American Corp]]></category>
		<category><![CDATA[WAG]]></category>
		<category><![CDATA[Walgreen Company]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=89481</guid>
		<description><![CDATA[The leading provider of prescriptions and related health care services in the US, CVS Caremark Corporation (CVS) has decided to participate in the annual JP Morgan Healthcare Conference scheduled on January 10, 2012. The company will be represented by its president and CEO, Mr. Larry Merlo, at the conference. Currently, CVS Caremark is ranked among the top three pharmacy benefit managers (PBM) in the US. The other big players in this chart are Express Scripts (ESRX) and Medco Health Solutions (MHS). Together these three companies control roughly 50% of the market by covering approximately 240 million prescription drug consumers annually. Rhode Island-based CVS Caremark is a combination of a PBM as well as retail drug chain. In terms of contractual arrangements with large plan sponsors, CVS Caremark holds a leading ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/12/30/cvs-cvs-caremark-corporation-to-attend-healthcare-conference/89481/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(CHSI) Catalyst Health Solutions Beats Estimates</title>
		<link>http://www.stockbloghub.com/2011/11/02/chsi-catalyst-health-solutions-beats-estimates/86361</link>
		<comments>http://www.stockbloghub.com/2011/11/02/chsi-catalyst-health-solutions-beats-estimates/86361#comments</comments>
		<pubDate>Wed, 02 Nov 2011 21:01:25 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Financial]]></category>
		<category><![CDATA[Insurance Brokers]]></category>
		<category><![CDATA[AirShares EU Carbon Allowances]]></category>
		<category><![CDATA[ASO]]></category>
		<category><![CDATA[Catalyst Health Solutions Inc]]></category>
		<category><![CDATA[CHSI]]></category>
		<category><![CDATA[MGM]]></category>
		<category><![CDATA[MGM Mirage]]></category>
		<category><![CDATA[Pacific Booker Minerals Inc.]]></category>
		<category><![CDATA[PBM]]></category>
		<category><![CDATA[W Holding Company Inc]]></category>
		<category><![CDATA[WHI]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=86361</guid>
		<description><![CDATA[Catalyst Health Solutions Inc. (CHSI) reported third-quarter operating earnings of 63 cents per share, beating the Zacks Consensus Estimate of 61 cents. The results also compare favorably with earnings of 51 cents in the prior-year quarter. Operating earnings in the reported quarter exclude the impact of non-recurring items such as transaction costs and integration expenses related to the Walgreens Health Initiatives Inc. (WHI) acquisition and amortization related to acquisitions. The year-over-year increase was attributable to strong prescription volume growth, which supported the top-line and improved operational performance. Besides, the acquisitions of WHI and FutureScripts were significant and provided meaningful earnings growth. However, the acquisitions led to additional expenses as well thereby, partially setting off  earnings growth. Net income reported by Catalyst Health was $15.2 million or 31 cents per share, ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/11/02/chsi-catalyst-health-solutions-beats-estimates/86361/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(WAG) Walgreen Posts Encouraging Quarter</title>
		<link>http://www.stockbloghub.com/2011/10/07/wag-walgreen-posts-encouraging-quarter/84159</link>
		<comments>http://www.stockbloghub.com/2011/10/07/wag-walgreen-posts-encouraging-quarter/84159#comments</comments>
		<pubDate>Fri, 07 Oct 2011 16:26:39 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Drug Stores]]></category>
		<category><![CDATA[Services]]></category>
		<category><![CDATA[Catalyst Health Solutions Inc]]></category>
		<category><![CDATA[CHSI]]></category>
		<category><![CDATA[CVS]]></category>
		<category><![CDATA[CVS Caremark Corporation]]></category>
		<category><![CDATA[ESRX]]></category>
		<category><![CDATA[Express Scripts Inc.]]></category>
		<category><![CDATA[Pacific Booker Minerals Inc.]]></category>
		<category><![CDATA[PBM]]></category>
		<category><![CDATA[RAD]]></category>
		<category><![CDATA[Rite Aid Corporation]]></category>
		<category><![CDATA[WAG]]></category>
		<category><![CDATA[Walgreen Company]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=84159</guid>
		<description><![CDATA[Walgreen (WAG) reported adjusted earnings of 57 cents per share in the fourth quarter of fiscal 2011, beating the Zacks Consensus Estimate of 55 cents and were 38.3% higher than the year-ago quarter. Results for the quarter excluded an after-tax gain of 30 cents per share associated with the company’s sale of pharmacy benefits management (PBM) business, Walgreens Health Initiatives, to Catalyst Health Solutions (CHSI). The result includes negative impact of 2 cents per share from Walgreen’s acquisition of drugstore.com and restructuring and restructuring-related costs of a penny per share associated with the company’s Rewiring for Growth initiative. The year-ago quarter included negative impact of 4 cents per share from costs associated with the Duane Reade acquisition and 1 cent towards costs associated with Rewiring for Growth. For fiscal 2011, ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/10/07/wag-walgreen-posts-encouraging-quarter/84159/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(CVS) CVS Caremark Analyst Maintains Shares at Neutral</title>
		<link>http://www.stockbloghub.com/2011/09/11/cvs-cvs-caremark-analyst-maintains-shares-at-neutral/82891</link>
		<comments>http://www.stockbloghub.com/2011/09/11/cvs-cvs-caremark-analyst-maintains-shares-at-neutral/82891#comments</comments>
		<pubDate>Sun, 11 Sep 2011 16:43:20 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Drug Stores]]></category>
		<category><![CDATA[Services]]></category>
		<category><![CDATA[AET]]></category>
		<category><![CDATA[Aetna Inc.]]></category>
		<category><![CDATA[CVS]]></category>
		<category><![CDATA[CVS Caremark Corporation]]></category>
		<category><![CDATA[ESRX]]></category>
		<category><![CDATA[Express Scripts Inc.]]></category>
		<category><![CDATA[FEP]]></category>
		<category><![CDATA[Franklin Electronic Publishers Inc]]></category>
		<category><![CDATA[MedcoHealth Solutions Inc.]]></category>
		<category><![CDATA[MHS]]></category>
		<category><![CDATA[Pacific Booker Minerals Inc.]]></category>
		<category><![CDATA[PBM]]></category>
		<category><![CDATA[UAM]]></category>
		<category><![CDATA[Universal American Corp]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=82891</guid>
		<description><![CDATA[Recently, we reiterated our Neutral recommendation on CVS Caremark Corporation (CVS) with a target price of $38.00. CVS reported an adjusted EPS of 65 cents in the second quarter of 2011, surpassing the Zacks Consensus Estimate by a penny but meeting the year-ago quarter’s adjusted EPS. After a period of sluggish performance, CVS’ Pharmacy Benefit Management (PBM) segment grew for the second consecutive quarter. During the quarter, this segment recorded a robust 23.2% year-over-year increase in revenues to reach $14.6 billion. The year-over upside was primarily driven by a 12-year contract with Aetna (AET), under which CVS provides PBM services to Aetna customers as well as the new acquisition of the Medicare Part D business of Universal American Corp (UAM). The company is also confident of achieving further growth in ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/09/11/cvs-cvs-caremark-analyst-maintains-shares-at-neutral/82891/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(CHSI) Catalyst Health Solutions Performs Well</title>
		<link>http://www.stockbloghub.com/2011/08/05/chsi-catalyst-health-solutions-performs-well/80594</link>
		<comments>http://www.stockbloghub.com/2011/08/05/chsi-catalyst-health-solutions-performs-well/80594#comments</comments>
		<pubDate>Fri, 05 Aug 2011 17:43:04 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Financial]]></category>
		<category><![CDATA[Insurance Brokers]]></category>
		<category><![CDATA[Catalyst Health Solutions Inc]]></category>
		<category><![CDATA[CHSI]]></category>
		<category><![CDATA[CVS]]></category>
		<category><![CDATA[CVS Caremark Corporation]]></category>
		<category><![CDATA[ESRX]]></category>
		<category><![CDATA[Express Scripts Inc.]]></category>
		<category><![CDATA[Pacific Booker Minerals Inc.]]></category>
		<category><![CDATA[PBM]]></category>
		<category><![CDATA[WAG]]></category>
		<category><![CDATA[Walgreen Company]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=80594</guid>
		<description><![CDATA[Catalyst Health Solutions Inc. (CHSI) reported second-quarter operating earnings of 53 cents per share, at par with the Zacks Consensus Estimate. The results compare favorably with earnings of 46 cents in the prior-year quarter. Catalyst Health’s operating earnings in the reported quarter excludes the impact of non-recurring items such as costs related to Walgreens Health Initiatives Inc. (&#8220;WHI&#8221;) acquisition and amortization of FutureScripts related intangible assets. Including amortization adjustments, net income reported by Catalyst Health was $12.3 million or 25 cents per share, substantially down from $19.5 million or 44 cents in the prior-year quarter. The year-over-year increase was attributable to a strong marketing strategy that supported the top-line and improved operational performance. Besides, the acquisition of WHI was significant and provided meaningful growth in earnings. However, it led to ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/08/05/chsi-catalyst-health-solutions-performs-well/80594/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(ESRX) Express Scripts Revenue Rises &#8211; Earnings Report In Line</title>
		<link>http://www.stockbloghub.com/2011/08/04/esrx-express-scripts-revenue-rises-earnings-report-in-line/79677</link>
		<comments>http://www.stockbloghub.com/2011/08/04/esrx-express-scripts-revenue-rises-earnings-report-in-line/79677#comments</comments>
		<pubDate>Thu, 04 Aug 2011 16:58:45 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Management Services]]></category>
		<category><![CDATA[Services]]></category>
		<category><![CDATA[ASR]]></category>
		<category><![CDATA[ESRX]]></category>
		<category><![CDATA[Express Scripts Inc.]]></category>
		<category><![CDATA[Grupo Aeroportuario Del Sureste SA de CV]]></category>
		<category><![CDATA[MedcoHealth Solutions Inc.]]></category>
		<category><![CDATA[MHS]]></category>
		<category><![CDATA[Pacific Booker Minerals Inc.]]></category>
		<category><![CDATA[PBM]]></category>
		<category><![CDATA[WellPoint Inc.]]></category>
		<category><![CDATA[WLP]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=79677</guid>
		<description><![CDATA[Express Scripts Inc.’s (ESRX) second quarter 2011 earnings of 71 cents per share (excluding special items) were in line with the Zacks Consensus Estimate but were well above the year-ago adjusted earnings of 60 cents per share. The jump in earnings is attributable to reduced selling, general and administrative expenses and a lower share count as compared with the year-ago quarter. Quarterly Details Second quarter revenues of $11.36 billion surpassed the Zacks Consensus Estimate of $11.32 billion and the year ago revenues of $11.29 billion. Adjusted gross profit for the quarter improved 4.5% to $812.6 million, and adjusted selling, general and administrative expenses decreased 8.5% to $194.6 million. Total claims at Express Scripts for the reported quarter came in at 161.4 million against 164.5 million in the second quarter of ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/08/04/esrx-express-scripts-revenue-rises-earnings-report-in-line/79677/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(MHS) Medco Health Solutions 2011 Second Quarter Earnings Preview</title>
		<link>http://www.stockbloghub.com/2011/07/20/mhs-medco-health-solutions-2011-second-quarter-earnings-preview/79454</link>
		<comments>http://www.stockbloghub.com/2011/07/20/mhs-medco-health-solutions-2011-second-quarter-earnings-preview/79454#comments</comments>
		<pubDate>Wed, 20 Jul 2011 15:27:44 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Drug Stores]]></category>
		<category><![CDATA[Services]]></category>
		<category><![CDATA[CVS]]></category>
		<category><![CDATA[CVS Caremark Corporation]]></category>
		<category><![CDATA[FEP]]></category>
		<category><![CDATA[Franklin Electronic Publishers Inc]]></category>
		<category><![CDATA[MedcoHealth Solutions Inc.]]></category>
		<category><![CDATA[MHS]]></category>
		<category><![CDATA[Pacific Booker Minerals Inc.]]></category>
		<category><![CDATA[PBM]]></category>
		<category><![CDATA[UNH]]></category>
		<category><![CDATA[Unitedhealth Group Inc.]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=79454</guid>
		<description><![CDATA[Medco Health Solutions Inc. (MHS) is scheduled to release its second-quarter 2011 earnings on July 21, 2011 before the market opens. The company is expected to report EPS of 94 cents on revenues of $17.08 billion during the quarter, according to Zacks Consensus Estimates. With respect to earnings surprises, Medco has exceeded the expectations in three out of the trailing four quarters. During the fourth quarter of fiscal 2010, the company reported in line results. The company has positive average earnings surprise of 2.70%. Along with the first quarter results, Medco raised its guidance for fiscal 2011 based on solid growth across all its segments. The company expects to deliver adjusted EPS in the range of $4.02-$4.12 (previous range of $3.80-$3.93) representing growth of 13%–16%. Previous Quarter Highlights Medco reported ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/07/20/mhs-medco-health-solutions-2011-second-quarter-earnings-preview/79454/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(WAG) Walgreens Debuts Web Pickup in Chicago</title>
		<link>http://www.stockbloghub.com/2011/06/29/wag-walgreens-debuts-web-pickup-in-chicago/77715</link>
		<comments>http://www.stockbloghub.com/2011/06/29/wag-walgreens-debuts-web-pickup-in-chicago/77715#comments</comments>
		<pubDate>Wed, 29 Jun 2011 15:36:12 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Drug Stores]]></category>
		<category><![CDATA[Services]]></category>
		<category><![CDATA[ESRX]]></category>
		<category><![CDATA[Express Scripts Inc.]]></category>
		<category><![CDATA[Pacific Booker Minerals Inc.]]></category>
		<category><![CDATA[PBM]]></category>
		<category><![CDATA[WAG]]></category>
		<category><![CDATA[Walgreen Company]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=77715</guid>
		<description><![CDATA[Leading retail pharmacy chain Walgreen Co. (WAG) has recently undertaken an innovative initiative to enhance its sales and distribution by launching Web Pickup service across Chicago. The program will enable customers to shop online at Walgreens.com and pick up the placed orders at the Walgreen stores within an hour. The non-prescription items will be available online through the service. The service is already available at 27 Walgreen stores in California. However, the company has chosen Chicago for the first full market roll out of the Web Pickup program. Presently, Web Pickup is available at 300 locations in the Chicago metropolitan area. The full market roll out across 480 locations is expected to be completed by August, 2011. Walgreen offers pharmacy benefit management (PBM), mail service, home care and specialty pharmacy ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/06/29/wag-walgreens-debuts-web-pickup-in-chicago/77715/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(CVS) CVS Caremark to Manage CalPERS PPO</title>
		<link>http://www.stockbloghub.com/2011/06/22/cvs-cvs-caremark-to-manage-calpers-ppo/77019</link>
		<comments>http://www.stockbloghub.com/2011/06/22/cvs-cvs-caremark-to-manage-calpers-ppo/77019#comments</comments>
		<pubDate>Wed, 22 Jun 2011 14:58:40 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Drug Stores]]></category>
		<category><![CDATA[Services]]></category>
		<category><![CDATA[AET]]></category>
		<category><![CDATA[Aetna Inc.]]></category>
		<category><![CDATA[CVS]]></category>
		<category><![CDATA[CVS Caremark Corporation]]></category>
		<category><![CDATA[FEP]]></category>
		<category><![CDATA[Franklin Electronic Publishers Inc]]></category>
		<category><![CDATA[MedcoHealth Solutions Inc.]]></category>
		<category><![CDATA[MHS]]></category>
		<category><![CDATA[Pacific Booker Minerals Inc.]]></category>
		<category><![CDATA[PBM]]></category>
		<category><![CDATA[Polypore International Inc]]></category>
		<category><![CDATA[PPO]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=77019</guid>
		<description><![CDATA[Recently, the California Public Employees’ Retirement System (CalPERS) selected CVS Caremark (CVS) to manage pharmacy benefits for its preferred provider organization (PPO) health plans, catering to more than 346,000 members. The three-year contract, to be effective from January 1, 2012, represents about $565 million in annual drug spending. The contract also has the option of two one-year extensions. Prior to CVS, Medco Health Solutions (MHS) has been managing the business from July 1, 2006, which is dated to expire on December 31, 2011. CalPERS is presently working with both Medco and CVS to ensure a smooth transition for its members and physicians. This contract is significant for CVS as its pharmacy benefit management (PBM) business has been witnessing several challenges over the past few quarters. CalPERS, which spends approximately $7 ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/06/22/cvs-cvs-caremark-to-manage-calpers-ppo/77019/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(CVS) CVS Caremark Analyst Maintains Neutral on Shares</title>
		<link>http://www.stockbloghub.com/2011/06/04/cvs-cvs-caremark-analyst-maintains-neutral-on-shares/75294</link>
		<comments>http://www.stockbloghub.com/2011/06/04/cvs-cvs-caremark-analyst-maintains-neutral-on-shares/75294#comments</comments>
		<pubDate>Sun, 05 Jun 2011 04:20:24 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Drug Stores]]></category>
		<category><![CDATA[Services]]></category>
		<category><![CDATA[AET]]></category>
		<category><![CDATA[Aetna Inc.]]></category>
		<category><![CDATA[CVS]]></category>
		<category><![CDATA[CVS Caremark Corporation]]></category>
		<category><![CDATA[FEP]]></category>
		<category><![CDATA[Franklin Electronic Publishers Inc]]></category>
		<category><![CDATA[MedcoHealth Solutions Inc.]]></category>
		<category><![CDATA[MHS]]></category>
		<category><![CDATA[Pacific Booker Minerals Inc.]]></category>
		<category><![CDATA[PBM]]></category>
		<category><![CDATA[UAM]]></category>
		<category><![CDATA[Universal American Corp]]></category>
		<category><![CDATA[WAG]]></category>
		<category><![CDATA[Walgreen Company]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=75294</guid>
		<description><![CDATA[Recently, we reiterated our Neutral recommendation on CVS Caremark Corporation (CVS) with a target price of $41.00. CVS Caremark reported an adjusted EPS of 57 cents in the first quarter of 2011, beating the Zacks Consensus Estimate of 55 cents but trailing the year-ago quarter’s adjusted EPS of 60 cents. After sluggish performance in past several quarters, the Pharmacy Benefit Management (PBM) business of CVS registered a robust 18.4% year over year increase during the quarter to reach $14 billion. The significant upside in revenue was primarily attributed to the 12-year contract with Aetna (AET), under which CVS provides PBM services to Aetna customers. We are encouraged by the company’s initiative for further focus on its key-growth areas under the PBM segment including the acquisition of Universal American&#8216;s (UAM) Medicare ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/06/04/cvs-cvs-caremark-analyst-maintains-neutral-on-shares/75294/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(CHSI) Catalyst Health Solutions First Quarter 2011 Earnings Soar!</title>
		<link>http://www.stockbloghub.com/2011/05/09/chsi-catalyst-health-solutions-first-quarter-2011-earnings-soar/73640</link>
		<comments>http://www.stockbloghub.com/2011/05/09/chsi-catalyst-health-solutions-first-quarter-2011-earnings-soar/73640#comments</comments>
		<pubDate>Mon, 09 May 2011 21:34:42 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Financial]]></category>
		<category><![CDATA[Insurance Brokers]]></category>
		<category><![CDATA[Catalyst Health Solutions Inc]]></category>
		<category><![CDATA[CHSI]]></category>
		<category><![CDATA[CVS]]></category>
		<category><![CDATA[CVS Caremark Corporation]]></category>
		<category><![CDATA[ESRX]]></category>
		<category><![CDATA[Express Scripts Inc.]]></category>
		<category><![CDATA[Pacific Booker Minerals Inc.]]></category>
		<category><![CDATA[PBM]]></category>
		<category><![CDATA[WAG]]></category>
		<category><![CDATA[Walgreen Company]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=73640</guid>
		<description><![CDATA[Catalyst Health Solutions Inc. (CHSI) reported first-quarter 2011 adjusted earnings of 52 cents per share, surpassing the Zacks Consensus Estimate of 50 cents. The results also compare favorably with earnings of 41 cents in the prior-year quarter. Catalyst Health’s adjusted earnings in the reported quarter exclude the adjustment for Walgreens Health Initiatives, Inc. (“WHI”) transaction related costs, amortization of FutureScripts related intangible assets and all other acquisition-related intangible assets. Including amortization adjustments, net income reported by Catalyst Health was $20.3 million or 45 cents per share, as against $17.4 million or 39 cents in the prior-year quarter. The year-over-year increase was attributable to a strong marketing strategy and leveraging its infrastructure and controlling overhead expenses. Besides, the strategic initiative of WHI was significant and provided meaningful growth in earnings. Quarter ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/05/09/chsi-catalyst-health-solutions-first-quarter-2011-earnings-soar/73640/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(WAG) Walgreen Faces Legal Battle Over Drugstore.com Aquisition</title>
		<link>http://www.stockbloghub.com/2011/04/07/wag-walgreen-faces-legal-battle-over-drugstore-com-aquisition/70410</link>
		<comments>http://www.stockbloghub.com/2011/04/07/wag-walgreen-faces-legal-battle-over-drugstore-com-aquisition/70410#comments</comments>
		<pubDate>Thu, 07 Apr 2011 17:25:35 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Drug Stores]]></category>
		<category><![CDATA[Services]]></category>
		<category><![CDATA[Catalyst Health Solutions Inc]]></category>
		<category><![CDATA[CHSI]]></category>
		<category><![CDATA[CVS]]></category>
		<category><![CDATA[CVS Caremark Corporation]]></category>
		<category><![CDATA[Pacific Booker Minerals Inc.]]></category>
		<category><![CDATA[PBM]]></category>
		<category><![CDATA[WAG]]></category>
		<category><![CDATA[Wal-Mart Stores Inc.]]></category>
		<category><![CDATA[Walgreen Company]]></category>
		<category><![CDATA[WMT]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=70410</guid>
		<description><![CDATA[The law firm of Brower Piven has announced a class action lawsuit in connection with the proposed acquisition of drugstore.com by Walgreen (WAG), one of the largest retail pharmacy chains in the US. The lawsuit has been filed by all the shareholders of drugstore.com in the Delaware Chancery Court. The complaint claims that the Board of Directors of drugstore.com infringed the state law while entering into a definitive merger agreement with Walgreen on March 24, 2011. Under the deal, Walgreen agreed to take over the online retailer, drugstore.com for $3.80 in cash per share, a 113 percent premium on the closing stock price of drugstore.com&#8217;s common stock on the last trading day prior to the agreement and a 102 percent premium over its 30-day average closing stock price. This represented ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/04/07/wag-walgreen-faces-legal-battle-over-drugstore-com-aquisition/70410/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(PBM) Catalyst Health Solutions Acquires FutureScripts</title>
		<link>http://www.stockbloghub.com/2010/09/14/pbm-catalyst-health-solutions-acquires-futurescripts/51475</link>
		<comments>http://www.stockbloghub.com/2010/09/14/pbm-catalyst-health-solutions-acquires-futurescripts/51475#comments</comments>
		<pubDate>Tue, 14 Sep 2010 20:22:58 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Basic Materials]]></category>
		<category><![CDATA[Copper]]></category>
		<category><![CDATA[Catalyst Health Solutions Inc]]></category>
		<category><![CDATA[CHSI]]></category>
		<category><![CDATA[CVS]]></category>
		<category><![CDATA[CVS Caremark Corporation]]></category>
		<category><![CDATA[ESRX]]></category>
		<category><![CDATA[Express Scripts Inc.]]></category>
		<category><![CDATA[JEF]]></category>
		<category><![CDATA[Jefferies Group Inc.]]></category>
		<category><![CDATA[MedcoHealth Solutions Inc.]]></category>
		<category><![CDATA[MHS]]></category>
		<category><![CDATA[Pacific Booker Minerals Inc.]]></category>
		<category><![CDATA[PBM]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=51475</guid>
		<description><![CDATA[Expanding its pharmacy benefit management (PBM) solutions, on Monday, Catalyst Health Solutions Inc. (CHSI) announced the purchase of all the PBM units of Independence Blue Cross (IBC) ? FutureScripts LLC and FutureScripts Secure LLC ? for an all cash transaction of $225 million. Both the entities have also received the regulatory approvals relevant for the deal. According to the terms laid, IBC has agreed to allow Catalyst Health to manage the former’s PBM service operations for a new 10-year term period. Moreover, IBC has included the future tax benefit for Catalyst Health in the deal value, based on the arrangement of the transaction. On August 4, both Catalyst Health and IBC had agreed on the terms of the deal. While Jefferies &#38; Company Inc. of Jefferies Group Inc. (JEF) acted ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2010/09/14/pbm-catalyst-health-solutions-acquires-futurescripts/51475/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(AET) Aetna and CVS Caremark Strike Deal</title>
		<link>http://www.stockbloghub.com/2010/08/02/aet-aetna-and-cvs-caremark-strike-deal/46056</link>
		<comments>http://www.stockbloghub.com/2010/08/02/aet-aetna-and-cvs-caremark-strike-deal/46056#comments</comments>
		<pubDate>Tue, 03 Aug 2010 04:22:32 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Health Care Plans]]></category>
		<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[AET]]></category>
		<category><![CDATA[Aetna Inc.]]></category>
		<category><![CDATA[CVS]]></category>
		<category><![CDATA[CVS Caremark Corporation]]></category>
		<category><![CDATA[ESRX]]></category>
		<category><![CDATA[Express Scripts Inc.]]></category>
		<category><![CDATA[Pacific Booker Minerals Inc.]]></category>
		<category><![CDATA[PBM]]></category>
		<category><![CDATA[WAG]]></category>
		<category><![CDATA[Walgreen Company]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=46056</guid>
		<description><![CDATA[Last week, health insurer Aetna Inc. (AET) announced that it has entered into a 12-year contract with pharmacy benefit manager (PBM) CVS Caremark (CVS). Pursuant to the agreement, Caremark will act as a PBM of Aetna’s prescription drug program for its Pharmacy Benefit Unit. In the United States, a PBM is a third-party administrator of prescription drug programs who are primarily responsible for processing and paying prescription drug claims. Caremark will take on responsibility for 9.7 million of Aetna’s members, besides being responsible for developing and maintaining the formulary, contracting with pharmacies, and negotiating discounts and rebates with drug manufacturers. The contract will help Aetna lower medical costs for its members on the back of price discounts from retail pharmacies, rebates from pharmaceutical manufacturers, and the efficiencies of mail-service pharmacies. ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2010/08/02/aet-aetna-and-cvs-caremark-strike-deal/46056/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(ESRX) Express Scripts Tops Expectations and Guides Up</title>
		<link>http://www.stockbloghub.com/2010/02/25/esrx-express-scripts-tops-expectations-and-guides-up/29029</link>
		<comments>http://www.stockbloghub.com/2010/02/25/esrx-express-scripts-tops-expectations-and-guides-up/29029#comments</comments>
		<pubDate>Thu, 25 Feb 2010 20:16:21 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Management Services]]></category>
		<category><![CDATA[Services]]></category>
		<category><![CDATA[CVS]]></category>
		<category><![CDATA[CVS Caremark Corporation]]></category>
		<category><![CDATA[ESRX]]></category>
		<category><![CDATA[Express Scripts Inc.]]></category>
		<category><![CDATA[MedcoHealth Solutions Inc.]]></category>
		<category><![CDATA[MHS]]></category>
		<category><![CDATA[Pacific Booker Minerals Inc.]]></category>
		<category><![CDATA[PBM]]></category>
		<category><![CDATA[WellPoint Inc.]]></category>
		<category><![CDATA[WLP]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=29029</guid>
		<description><![CDATA[Express Scripts Inc. (ESRX) announced better-than-expected results with fourth-quarter earnings of 97 cents per share, 7 cents above the Zacks Consensus Estimate. Earnings increased 14.1% from the year-ago period. Full year earnings were $3.58 per share, 12 cents above the Zacks Consensus Estimate and well above the year ago earnings of $3.18. Fourth quarter revenues increased a whopping 49% to $8.2 billion. Full year revenues increased 12.6% to $24.7 billion. We believe that the company benefited from new business gained through its acquisition of NextRx, the pharmacy business management (PBM) segment of WellPoint Inc. (WLP). NextRx provides PBM services to approximately 25 million Americans and manages more than 265 million adjusted prescriptions annually. We view Express Scripts’ acquisition of NextRx as a smart strategic move. The aligned business model should ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2010/02/25/esrx-express-scripts-tops-expectations-and-guides-up/29029/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(MHS) Medco Health Solutions Beats &#8211; Provides Strong Outlook</title>
		<link>http://www.stockbloghub.com/2009/11/29/mhs-medco-health-solutions-beats-provides-strong-outlook/21427</link>
		<comments>http://www.stockbloghub.com/2009/11/29/mhs-medco-health-solutions-beats-provides-strong-outlook/21427#comments</comments>
		<pubDate>Mon, 30 Nov 2009 04:56:57 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Drug Stores]]></category>
		<category><![CDATA[Services]]></category>
		<category><![CDATA[MedcoHealth Solutions Inc.]]></category>
		<category><![CDATA[MHS]]></category>
		<category><![CDATA[Pacific Booker Minerals Inc.]]></category>
		<category><![CDATA[PBM]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=21427</guid>
		<description><![CDATA[Medco Health Solutions (MHS) reported third quarter earnings of 75 cents per share, well above the Zacks Consensus Estimate of 71 cents as well as 63 cents reported in the year-ago period. Medco, the largest pharmacy benefit manager (PBM) recorded an increase of 17.8% in revenues which came in at $14.8 billion primarily driven by contributions from significant new client wins, as well as price inflation on brand-name drugs, partially offset by higher volumes of lower-priced generic drugs. Revenues from MHS’ specialty pharmacy segment, Accredo Health Group increased 19.2% to $2.4 billion primarily due to significant addition of new clients and organic growth. The reported quarter has been quite significant for Medco. The huge acceptance of generic drugs (they have higher margins for PBMs compared to branded drugs) is evident ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2009/11/29/mhs-medco-health-solutions-beats-provides-strong-outlook/21427/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

